Challenges of international oncology trial collaboration—a call to action

por Tang, Monica, Joensuu, Heikki, Simes, Robert J., Price, Timothy J., Yip, Sonia, Hague, Wendy, Sjoquist, Katrin M., Zalcberg, John
Publicado 2019

Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patien...

por Lawrence, Nicola J., Chan, Howard, Toner, Guy, Stockler, Martin R., Martin, Andrew, Yip, Sonia, Wong, Nicole, Yeung, Annie, Mazhar, Danish, Pashankar, Farzana, Frazier, Lindsay, McDermott, Ray, Walker, Roderick, Tan, Hsiang, Davis, Ian D., Grimison, Peter
Publicado 2018

AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pa...

por Oar, Andrew, Lee, Mark, Le, Hien, Wilson, Kate, Aiken, Chris, Chantrill, Lorraine, Simes, John, Nguyen, Nam, Barbour, Andrew, Samra, Jaswinder, Sjoquist, Katrin M., Moore, Alisha, Espinoza, David, Gebski, Val, Yip, Sonia, Chu, Julie, Kneebone, Andrew, Goldstein, David
Publicado 2021

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

por Antill, Yoland, Kok, Peey-Sei, Robledo, Kristy, Yip, Sonia, Cummins, Michelle, Smith, Deborah, Spurdle, Amanda, Barnes, Elizabeth, Lee, Yeh Chen, Friedlander, Michael, Baron-Hay, Sally, Shannon, Catherine, Coward, Jermaine, Beale, Philip, Goss, Geraldine, Meniawy, Tarek, Lombard, Janine, Andrews, John, Stockler, Martin R, Mileshkin, Linda
Publicado 2021

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study

por Sim, Hao-Wen, McDonald, Kerrie L, Lwin, Zarnie, Barnes, Elizabeth H, Rosenthal, Mark, Foote, Matthew C, Koh, Eng-Siew, Back, Michael, Wheeler, Helen, Sulman, Erik P, Buckland, Michael E, Fisher, Lauren, Leonard, Robyn, Hall, Merryn, Ashley, David M, Yip, Sonia, Simes, John, Khasraw, Mustafa
Publicado 2021

Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial

por Kok, Peey Sei, Forde, Patrick M, Hughes, Brett, Sun, Zhuoxin, Brown, Chris, Ramalingam, Suresh, Cook, Alistair, Lesterhuis, Willem Joost, Yip, Sonia, O’Byrne, Ken, Pavlakis, Nick, Brahmer, Julie, Anagnostou, Valsamo, Ford, Kate, Fitzpatrick, Karen, Bricker, Alison, Cummins, Michelle M, Stockler, Martin, Nowak, Anna K
Publicado 2022

Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA)

por Smith, Deborah, Robledo, Kristy P., Yip, Sonia, Cummins, Michelle M., Kok, Peey-Sei, Lee, Yeh Chen, Friedlander, Michael, Baron-Hay, Sally, Shannon, Catherine, Coward, Jermaine, Beale, Philip, Goss, Geraldine, Meniawy, Tarek, Lombard, Janine, Spurdle, Amanda B., Andrews, John, Stockler, Martin R., Mileshkin, Linda, Antill, Yoland
Publicado 2022

Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma

por Kong, Benjamin Y, Sim, Hao-Wen, Barnes, Elizabeth H, Nowak, Anna K, Hovey, Elizabeth J, Jeffree, Rosalind, Harrup, Rosemary, Parkinson, Jonathon, Gan, Hui K, Pinkham, Mark B, Yip, Sonia, Hall, Merryn, Tu, Emily, Carter, Candace, Koh, Eng-Siew, Lwin, Zarnie, Dowling, Anthony, Simes, John S, Gedye, Craig
Publicado 2022

MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a...

por Siu, Ho Wai Derrick, Tebbutt, Niall, Chantrill, Lorraine, Karapetis, Chris, Steer, Christopher, Wilson, Kate, Espinoza, David, Bailey, Lisa, Yip, Sonia, Cuff, Jeff, Pavlakis, Nick, Thavaneswaran, Subotheni, Briscoe, Karen, Srivastav, Ratnesh, Shannon, Jennifer, Segelov, Eva, Tie, Jeannie, Caird, Susan, Francesconi, Alessandra, Price, Timothy, Wuttke, Melanie, Ladwa, Rahul, Sjoquist, Katrin, Burge, Matthew
Publicado 2021

CTLA4 protects against maladaptive cytotoxicity during the differentiation of effector and follicular CD4(+) T cells

por Hao, Yuwei, Miraghazadeh, Bahar, Chand, Rochna, Davies, Ainsley R., Cardinez, Chelisa, Kwong, Kristy, Downes, Morgan B., Sweet, Rebecca A., Cañete, Pablo F., D’Orsogna, Lloyd J., Fulcher, David A., Choo, Sharon, Yip, Desmond, Peters, Geoffrey, Yip, Sonia, Witney, Matthew J., Nekrasov, Maxim, Feng, Zhi-Ping, Tscharke, David C., Vinuesa, Carola G., Cook, Matthew C.
Publicado 2023

INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by...

por Lam, Lyn Ley, Pavlakis, Nick, Shitara, Kohei, Sjoquist, Katrin M., Martin, Andrew J., Yip, Sonia, Kang, Yoon-Koo, Bang, Yung-Jue, Chen, Li-Tzong, Moehler, Markus, Bekaii-Saab, Tanios, Alcindor, Thierry, O’Callaghan, Christopher J., Tebbutt, Niall C., Hague, Wendy, Chan, Howard, Rha, Sun Young, Lee, Keun-Wook, Gebski, Val, Jaworski, Anthony, Zalcberg, John, Price, Timothy, Simes, John, Goldstein, David
Publicado 2023

LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study

por Kong, Benjamin Y, Sim, Hao-Wen, Nowak, Anna K, Yip, Sonia, Barnes, Elizabeth H, Day, Bryan W, Buckland, Michael E, Verhaak, Roel, Johns, Terrance, Robinson, Cleo, Thomas, Marc A, Giardina, Tindaro, Lwin, Zarnie, Scott, Andrew M, Parkinson, Jonathon, Jeffree, Rosalind, Lourenco, Richard de Abreu, Hovey, Elizabeth J, Cher, Lawrence M, Kichendasse, Ganessan, Khasraw, Mustafa, Hall, Merryn, Tu, Emily, Amanuel, Benhur, Koh, Eng-Siew, Gan, Hui K
Publicado 2021

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma

por Sim, Hao-Wen, Wachsmuth, Luke, Barnes, Elizabeth H, Yip, Sonia, Koh, Eng-Siew, Hall, Merryn, Jennens, Ross, Ashley, David M, Verhaak, Roel G, Heimberger, Amy B, Rosenthal, Mark A, Hovey, Elizabeth J, Ellingson, Benjamin M, Tognela, Annette, Gan, Hui K, Wheeler, Helen, Back, Michael, McDonald, Kerrie L, Long, Anne, Cuff, Katharine, Begbie, Stephen, Gedye, Craig, Mislang, Anna, Le, Hien, Johnson, Margaret O, Kong, Benjamin Y, Simes, John R, Lwin, Zarnie, Khasraw, Mustafa
Publicado 2023

Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP

por Stockler, Martin R., Martin, Andrew J., Davis, Ian D., Dhillon, Haryana M., Begbie, Stephen D., Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin M., McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy R., Pook, David W., Reaume, M. Neil, Sandhu, Shahneen, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G., Winter, Diana G., Yip, Sonia, Zhang, Alison Y., Zielinski, Robert R., Sweeney, Christopher J.
Publicado 2022